## **What is HCPCS code G0145 for?**
HCPCS Code G0145 refers to screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision. This method collects cervical cells or vaginal cells to prepare an enhanced Pap test specimen, allowing for more accurate evaluation compared to traditional smear techniques.
The automated system facilitates the processing and analysis of samples, improving detection of abnormalities such as abnormal cervical cytology that may be indicative of precancerous changes or risk for invasive cervical cancer. This type of screening is essential in identifying early signs of both cervical cancer and vaginal cancer, playing a critical role in preventive care for women.
Typically, the procedure includes specimen collection during a pelvic examination followed by preparation using the automated thin layer system to produce a clean, uniform monolayer of cells. The results are interpreted via a standardized reporting system that classifies the cellular findings and guides clinical management.
HCPCS code G0145 is commonly used in routine cervical cancer screening programs, including those targeted for patients with risk factors such as HIV infection, who may require more frequent monitoring. This code supports comprehensive screening efforts by enabling better detection sensitivity and specificity compared to conventional Pap tests or vaginal smears.
Because automated liquid-based cytology techniques have largely replaced conventional smears, G0145 represents a valuable procedure in modern women's health practices, ensuring accurate screening outcomes and timely identification of abnormalities.
## **Documentation requirements**
Providers must maintain complete and accurate medical records to support the use of HCPCS Code G0145. Key documentation elements include:
- Patient identification and demographic information.
- Clear documentation of the cervical or vaginal specimen collection during a pelvic examination.
- Record the use of an automated thin layer preparation system for sample processing.
- Include details of the screening performed by the automated system and manual rescreening under physician supervision.
- Documentation of the reporting system used to interpret the cytopathology results.
- Evidence that the screening is performed as part of a cervical cancer screening or vaginal cancer screening program.
- Indicate the clinical purpose of the test, such as primary screening test for cervical or vaginal cancer, or monitoring of abnormal cervical cytology.
- Include any relevant risk factors or conditions such as HIV infection if applicable.
- Confirmation that the test was conducted in compliance with Medicare coverage policies and billing guidelines.
- Maintain records for date of service, findings, and any follow-up plans documented by the ordering provider.
## **Billing requirements**
Billing for HCPCS Code G0145must include:
- The appropriate HCPCS code G0145.
- Corresponding ICD-10-CM diagnosis codes supporting cervical or vaginal cancer screening indications.
- Place of service codes indicating where the service was performed.
## **Other relevant codes**
- G0123 — Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision
- G0143 — Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision
- G0476 — Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test
Frequently asked questions
